Annual Cash & Cash Equivalents:
$215.37M+$134.07M(+164.91%)Summary
- As of today, PRAX annual cash & cash equivalents is $215.37 million, with the most recent change of +$134.07 million (+164.91%) on December 31, 2024.
- During the last 3 years, PRAX annual cash & cash equivalents has risen by +$76.67 million (+55.27%).
- PRAX annual cash & cash equivalents is now -27.39% below its all-time high of $296.61 million, reached on December 31, 2020.
Performance
PRAX Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$301.27M-$26.72M(-8.15%)Summary
- As of today, PRAX quarterly cash & cash equivalents is $301.27 million, with the most recent change of -$26.72 million (-8.15%) on June 30, 2025.
- Over the past year, PRAX quarterly cash & cash equivalents has dropped by -$50.60 million (-14.38%).
- PRAX quarterly cash & cash equivalents is now -23.26% below its all-time high of $392.57 million, reached on December 31, 2024.
Performance
PRAX Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PRAX Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +164.9% | -14.4% |
| 3Y3 Years | +55.3% | +82.1% |
| 5Y5 Years | +380.6% | - |
PRAX Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +249.5% | -23.3% | +270.6% |
| 5Y | 5-Year | -27.4% | +380.6% | -23.3% | +270.6% |
| All-Time | All-Time | -27.4% | +1099.8% | -23.3% | +572.3% |
PRAX Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $301.27M(-8.1%) |
| Mar 2025 | - | $327.99M(-16.4%) |
| Dec 2024 | $215.37M(+164.9%) | $392.57M(+10.0%) |
| Sep 2024 | - | $357.03M(+1.5%) |
| Jun 2024 | - | $351.88M(+69.6%) |
| Mar 2024 | - | $207.42M(+155.1%) |
| Dec 2023 | $81.30M(+31.9%) | $81.30M(-19.6%) |
| Sep 2023 | - | $101.08M(-18.7%) |
| Jun 2023 | - | $124.30M(+44.8%) |
| Mar 2023 | - | $85.82M(-14.6%) |
| Dec 2022 | $61.62M | $100.49M(-18.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $123.74M(-25.2%) |
| Jun 2022 | - | $165.40M(-25.7%) |
| Mar 2022 | - | $222.52M(-19.4%) |
| Dec 2021 | $138.70M(-53.2%) | $275.91M(-12.4%) |
| Sep 2021 | - | $314.97M(-7.4%) |
| Jun 2021 | - | $340.20M(+25.3%) |
| Mar 2021 | - | $271.41M(-8.7%) |
| Dec 2020 | $296.61M(+561.8%) | $297.21M(+159.0%) |
| Sep 2020 | - | $114.77M(+156.1%) |
| Dec 2019 | $44.81M(+149.7%) | $44.81M |
| Dec 2018 | $17.95M | - |
FAQ
- What is Praxis Precision Medicines, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Praxis Precision Medicines, Inc.?
- What is Praxis Precision Medicines, Inc. annual cash & cash equivalents year-on-year change?
- What is Praxis Precision Medicines, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Praxis Precision Medicines, Inc.?
- What is Praxis Precision Medicines, Inc. quarterly cash & cash equivalents year-on-year change?
What is Praxis Precision Medicines, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of PRAX is $215.37M
What is the all-time high annual cash & cash equivalents for Praxis Precision Medicines, Inc.?
Praxis Precision Medicines, Inc. all-time high annual cash & cash equivalents is $296.61M
What is Praxis Precision Medicines, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, PRAX annual cash & cash equivalents has changed by +$134.07M (+164.91%)
What is Praxis Precision Medicines, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of PRAX is $301.27M
What is the all-time high quarterly cash & cash equivalents for Praxis Precision Medicines, Inc.?
Praxis Precision Medicines, Inc. all-time high quarterly cash & cash equivalents is $392.57M
What is Praxis Precision Medicines, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, PRAX quarterly cash & cash equivalents has changed by -$50.60M (-14.38%)